FT. MEYERS, Fla., Dec 02, 2003 /PRNewswire via COMTEX/ -- Flexcin International, Inc. today announced the retail marketing launch of Flexcin, their breakthrough dietary supplement for joint health and mobility with the patented compound, CM8(TM).

"It is great news for joint pain and arthritis sufferers that we, at Flexcin International, are bringing our exclusive solution to retail stores," said Tamer Elsafy, CEO/President. "Featuring CM8 (Cetyl Myristoleate), as well as four other proven, all natural ingredients, there isn't another product available today that can match Flexcin's formula for effectiveness. Flexcin is clinically proven to improve joint health for Americans of all ages. We believe it is the ideal joint mobility solution for retailers who want to offer a product that contains high-end ingredients, yet remain cost effective. Flexcin's superior ingredients, coupled with our aggressive media/marketing plan, create a win-win situation for retail stores and consumers." Flexcin has begun a vigorous national radio and print advertising program in addition to a targeted national publicity campaign.

CM8 (Cetyl Myristoleate), the most powerful anti-inflammatory ingredient in Flexcin, was specially developed to improve recovery rates. Flexcin International required eight specific "markers" to achieve the desired effectiveness level that gives Flexcin its market superiority. Other specially developed, market-superior Flexcin ingredients include 120 mg of highly- refined Collagen Type II, their high-end custom-formulated Glucosamine complex for easier absorption into the bloodstream and enhanced for easy tolerance MSM. 

"Flexcin is a natural alternative that can be used in a broad range of conditions," stated renowned practicing internist and medical journalist, Dr. David Vastola. "It is inexpensive, easy to take, the body tolerates it well and it has CM8. It works! I am not aware of any other product like it."